Olav M. Bakke

Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective

Olav M. Bakke, Michael Manocchia, Francisco J. de Abajo et al. · Clinical Pharmacology & Therapeutics · 1995 · 209 citations

Hydroxylation of aromatic hydrocarbons in the rat

Olav M. Bakke, Ronald R. Scheline · Toxicology and Applied Pharmacology · 1970 · 179 citations

Biochemistry, Organic Chemistry, Toxicology +3

Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: Issues of safety

Olav M. Bakke, William M. Wardell, Louis Lasagna · Clinical Pharmacology & Therapeutics · 1984 · 98 citations

Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate

Rolf K. Berge, Olav M. Bakke · Biochemical Pharmacology · 1981 · 75 citations

Lipid Analysis, Health Sciences, Biochemistry +10

Hepatic enzymes, coash and long-chain acyl-coa in subcellular fractions as affected by drugs inducing peroxisomes and smooth endoplasmic reticulum

Rolf K. Berge, Asle Aarsland, Olav M. Bakke et al. · International Journal of Biochemistry · 1983 · 47 citations

Hepatology, Biochemistry, Long-chain Acyl-coa +13